143 related articles for article (PubMed ID: 20556513)
21. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells.
Lee IO; Lee KH; Pyo JH; Kim JH; Choi YJ; Lee YC
Helicobacter; 2007 Oct; 12(5):510-7. PubMed ID: 17760719
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene.
Reyes-Leon A; Atherton JC; Argent RH; Puente JL; Torres J
Infect Immun; 2007 Jul; 75(7):3445-54. PubMed ID: 17438024
[TBL] [Abstract][Full Text] [Related]
24. Antagonizing roles of SHP1 in the pathogenesis of Helicobacter pylori infection.
Chen S; Zhao H; Tian Y; Wu Q; Zhang J; Liu S; Zhang Y; Wu Y; Li B; Chen S; Wang Z; Xiao R; Ji X
Helicobacter; 2024; 29(2):e13066. PubMed ID: 38468575
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8.
Kim SY; Lee YC; Kim HK; Blaser MJ
Cell Microbiol; 2006 Jan; 8(1):97-106. PubMed ID: 16367869
[TBL] [Abstract][Full Text] [Related]
26. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K
Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404
[TBL] [Abstract][Full Text] [Related]
27. Interaction of omeprazole and Helicobacter pylori-induced nuclear factor-κB activation and mediators in gastric epithelial cells.
Peng YC; Huang LR; Shyu CL; Cheng CC; Ho SP
J Chin Med Assoc; 2014 Nov; 77(11):567-72. PubMed ID: 25205289
[TBL] [Abstract][Full Text] [Related]
28. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
Xu N; Zhang C; Jing L; Mou S; Cao X; Yu Z
Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942
[TBL] [Abstract][Full Text] [Related]
29. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
[TBL] [Abstract][Full Text] [Related]
30. Variant of Helicobacter pylori CagA proteins induce different magnitude of morphological changes in gastric epithelial cells.
Alfizah H; Ramelah M
Malays J Pathol; 2012 Jun; 34(1):29-34. PubMed ID: 22870595
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.
Crabtree JE; Covacci A; Farmery SM; Xiang Z; Tompkins DS; Perry S; Lindley IJ; Rappuoli R
J Clin Pathol; 1995 Jan; 48(1):41-5. PubMed ID: 7706517
[TBL] [Abstract][Full Text] [Related]
32. N-terminal region of
Zeng B; Chen C; Yi Q; Zhang X; Wu X; Zheng S; Li N; She F
J Med Microbiol; 2020 Mar; 69(3):457-464. PubMed ID: 32100714
[No Abstract] [Full Text] [Related]
33. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury.
Smoot DT; Elliott TB; Verspaget HW; Jones D; Allen CR; Vernon KG; Bremner T; Kidd LC; Kim KS; Groupman JD; Ashktorab H
Carcinogenesis; 2000 Nov; 21(11):2091-5. PubMed ID: 11062173
[TBL] [Abstract][Full Text] [Related]
34. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
Han BG; Kim HS; Rhee KH; Han HS; Chung MH
Pharmacol Res; 1995 Oct; 32(4):201-7. PubMed ID: 8866835
[TBL] [Abstract][Full Text] [Related]
35. Rebamipide, anti-gastric ulcer drug, up-regulates the induction of iNOS in proinflammatory cytokine-stimulated hepatocytes.
Tokuhara K; Hamada Y; Tanaka H; Yamada M; Ozaki T; Matsui K; Kamiyama Y; Nishizawa M; Ito S; Okumura T
Nitric Oxide; 2008 Feb; 18(1):28-36. PubMed ID: 17936043
[TBL] [Abstract][Full Text] [Related]
36. Review article: rebamipide and the digestive epithelial barrier.
Matysiak-Budnik T; Heyman M; Mégraud F
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():55-62. PubMed ID: 12925141
[TBL] [Abstract][Full Text] [Related]
37. Jak1/Stat3 is an upstream signaling of NF-κB activation in Helicobacter pylori-induced IL-8 production in gastric epithelial AGS cells.
Cha B; Lim JW; Kim H
Yonsei Med J; 2015 May; 56(3):862-6. PubMed ID: 25837197
[TBL] [Abstract][Full Text] [Related]
38. α-Lipoic Acid Inhibits Expression of IL-8 by Suppressing Activation of MAPK, Jak/Stat, and NF-κB in H. pylori-Infected Gastric Epithelial AGS Cells.
Choi JH; Cho SO; Kim H
Yonsei Med J; 2016 Jan; 57(1):260-4. PubMed ID: 26632410
[TBL] [Abstract][Full Text] [Related]
39. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling.
Handa O; Naito Y; Yoshikawa T
Biochem Pharmacol; 2007 Jun; 73(11):1697-702. PubMed ID: 17134680
[TBL] [Abstract][Full Text] [Related]
40. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
